ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 628,80
0,76%
Dow Jones
38 834,86
0,15%
DAX
18 131,97
0,32%
Brent Oil
84,855
1,14%
Bitcoin
65 148,58
-2,01%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Fulgent Genetics Inc (FLGT)

  7. Fulgent Genetics Inc (FLGT) Actualités

FLGT

Fulgent Genetics (FLGT)

Fulgent Genetics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:FLGT
DateHeureSourceTitreSymboleSociété
04/06/202422h57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FLGTFulgent Genetics Inc
03/06/202414h00Business WireFulgent Data at ASCO 2024 Highlights Antitumor Activity from Lead Therapeutic Oncology Candidate, FID-007, in Head and Neck CancerNASDAQ:FLGTFulgent Genetics Inc
24/05/202414h00Business WireFulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2024 Annual MeetingNASDAQ:FLGTFulgent Genetics Inc
16/05/202422h29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FLGTFulgent Genetics Inc
14/05/202422h05Business WireMoffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer TherapeuticsNASDAQ:FLGTFulgent Genetics Inc
03/05/202413h00Business WireFulgent Reports First Quarter 2024 Financial ResultsNASDAQ:FLGTFulgent Genetics Inc
11/04/202422h05Business WireFulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024NASDAQ:FLGTFulgent Genetics Inc
28/02/202413h00Business WireFulgent Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:FLGTFulgent Genetics Inc
13/02/202414h00Business WireFulgent Genetics to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024NASDAQ:FLGTFulgent Genetics Inc
10/02/202400h09Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:FLGTFulgent Genetics Inc
09/02/202414h31PR Newswire (US)Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic TestingNASDAQ:FLGTFulgent Genetics Inc
13/12/202303h43Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FLGTFulgent Genetics Inc
14/11/202322h30Business WireFulgent to Participate in the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:FLGTFulgent Genetics Inc
03/11/202321h05Business WireFulgent Shares Data from Two Poster Presentations at SITC 2023 Annual MeetingNASDAQ:FLGTFulgent Genetics Inc
03/11/202312h31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FLGTFulgent Genetics Inc
03/11/202312h00Business WireFulgent Reports Third Quarter 2023 Financial ResultsNASDAQ:FLGTFulgent Genetics Inc
25/10/202314h00Business WireFulgent Announces Two Poster Presentations at SITC 2023 Annual MeetingNASDAQ:FLGTFulgent Genetics Inc
17/10/202314h00Business WireFulgent Genetics to Announce Third Quarter 2023 Financial Results on Friday November 3, 2023NASDAQ:FLGTFulgent Genetics Inc
04/08/202313h00Business WireFulgent Reports Second Quarter 2023 Financial ResultsNASDAQ:FLGTFulgent Genetics Inc
24/07/202322h05GlobeNewswire Inc.Exagen Inc. Appoints Paul Kim to Board of DirectorsNASDAQ:FLGTFulgent Genetics Inc
18/07/202314h00Business WireFulgent Genetics to Announce Second Quarter 2023 Financial Results on Friday, August 4, 2023NASDAQ:FLGTFulgent Genetics Inc
06/06/202323h07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FLGTFulgent Genetics Inc
05/06/202314h30Business WireFulgent Data at ASCO 2023 Highlights Progress for Its Lead Therapeutic Oncology Candidate, FID-007, in Various CancersNASDAQ:FLGTFulgent Genetics Inc
18/05/202322h59Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FLGTFulgent Genetics Inc
18/05/202322h07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FLGTFulgent Genetics Inc
18/05/202322h05Business WireFulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2023 Annual MeetingNASDAQ:FLGTFulgent Genetics Inc
05/05/202313h00Business WireFulgent Reports First Quarter 2023 Financial ResultsNASDAQ:FLGTFulgent Genetics Inc
20/04/202322h05Business WireFulgent Genetics to Announce First Quarter 2023 Financial Results on Friday May 5, 2023NASDAQ:FLGTFulgent Genetics Inc
11/04/202314h00PR Newswire (US)Mission Bio Partners with Fulgent Genetics to Broaden Accessibility of Single-Cell Multi-Omics for Drug Development and Clinical ResearchNASDAQ:FLGTFulgent Genetics Inc
03/04/202312h17Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:FLGTFulgent Genetics Inc
 Showing the most relevant articles for your search:NASDAQ:FLGT

Dernières Valeurs Consultées

EU
BN
Danone
EU
LR
Legrand
EU
ACA
Credit Agricole
NYSE
KO
Coca Cola
EU
DG
Vinci
EU
EN
Bouygues
NASDAQ
NVDA
NVIDIA
EU
AI
Air Liquide
EU
GLE
Societe Generale
EU
CAP
Capgemini
EU
VK
Vallourec
EU
VIV
Vivendi
NASDAQ
AAPL
Apple
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés